Serebryany honored for work on cataracts
Growing up in Russia, Evgeny “Eugene” Serebryany mostly enjoyed humanities-related courses. He developed new interests after he moved to the U.S. as a teenager and faced a language barrier.
At his Massachusetts high school, Serebryany began to translate Russian poetry, which he still does, and he started to embrace science.
Evgeny Serebryany was approved for a green card in time to receive the NIH award that funds most of his research into new treatments for cataracts.
“Experimental science offered a way to contribute to advancement of knowledge in a very concrete way,” he said.
His path wasn’t always easy. “Immigration status has been the biggest roadblock,” he said.
As an international student, he wasn’t eligible for federal grants or loans for college, and his family couldn’t afford the tuition. Yale University offered him full financial aid from endowment funds, and he earned a bachelor’s degree in molecular biophysics and biochemistry while doing research in the laboratory of .
Federal training grants also cannot fund graduate students who lack permanent U.S. residency. The Massachusetts Institute of Technology granted Serebryany a private fellowship, and he completed his Ph.D. in biochemistry with . He is now a postdoctoral fellow in research group at Harvard.
Serebryany said he is grateful to both Yale and MIT for the education he received “on their own dime.”
As a postdoc, he petitioned the U.S. government for a green card based on exceptional scientific ability in the national interest. His request was approved in February 2018, and he gained permanent resident status in time to receive the National Institutes of Health National Research Service Award, which now funds most of his research.
“I couldn’t travel abroad. Now I can,” he said. “But beyond the funding and travel restrictions, just the fear of someday not being able to extend my string of temporary statuses … and then having to leave or get deported, made it that much harder to focus on the research.
“The sense of freedom and security that a green card gives, though not complete, is priceless.”
Disulfide bonds offer new insights into cataracts
Cataracts impair vision by clouding the eye’s lens, mostly in older people. Most proteins in the lens belong to the crystallin family; as we age, the crystallin proteins can start to clump together, causing the lens to scatter light and become less transparent.
Serebryany and his colleagues used biochemical approaches including mass spectrometry and mutational analysis to develop new mechanistic insights into disulfide bond formation and exchange in crystallins, which led them to propose a “redox hot potato” competition model; under physiological conditions, stable gamma-crystallin molecules in the lens continually exchange disulfides. However, if a stable molecule passes the disulfide to a structurally unstable one, the latter becomes trapped in a structure prone to aggregation, which results in light scattering, the hallmark of cataracts.
Cataracts can be addressed in two ways. When prescription eyeglasses become ineffective, patients are left with the option of surgery, which is effective but expensive and not available to everyone. Cataracts remain the world’s leading cause of blindness. The work of Serebryany and his colleagues may pave the way to lower-cost therapeutic treatment.
Read his prize-winning paper .
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Cedeño–Rosario and Kaweesa win research award
The award honors outstanding early-career scientists studying cancer, infectious disease and basic science.
ASBMB names 2026 award winners
Check out their lectures at the annual meeting in March in the Washington, D.C., metro area.
Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.
Castiglione and Ingolia win Keck Foundation grants
They will receive at least $1 million of funding to study the biological mechanisms that underly birds' longevity and sequence–function relationships of intrinsically disordered proteins.
How undergrad research catalyzes scientific careers
Undergraduate research doesn’t just teach lab skills, it transforms scientists. For Antonio Rivera and Julissa Cruz–Bautista, joining a lab became a turning point, fostering critical thinking, persistence and research identity.
Simcox and Gisriel receive mentoring award
They were honored for contributing their time, knowledge, energy and enthusiasm to mentoring postdocs in their labs.